MACULAR DEGENERATION TREATMENT MARKET ANALYSIS

Macular Degeneration Treatment Market, By Type (Dry Age-related Macular Degeneration and Wet Age-related Macular Degeneration), By Stage Of Disease (Early-stage AMD, Intermediate AMD, and Late-stage AMD), By Route Of Administration (Intravenous Route and Intravitreal Route), By Sales Channel (Ambulatory Surgical Centres, Hospitals, and Other Sales Channels), and By Geography (North America Europe, Asia-Pacific, South America, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Aug 2022
Code : CMI5149
Pages :174
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Companies covered:

Bayer AG, REGENXBIO Inc., Aerie Pharmaceutical Inc., Panoptica, Pfizer Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceutical Inc., Novartis AG, and Bausch Health Companies Inc., among others

Competitive Landscape:

Hoffmann-La Roche Ltd
Novartis AG
Pfizer Inc.
Panoptica
Bausch Health Companies Inc.
Regeneron Pharmaceutical Inc.
Aerie Pharmaceutical Inc.
REGENXBIO Inc.
Bayer AG

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Macular Degeneration Treatment Market To Be Valued at US$ 13,195.7 Mn by 2028

Credibility and Certifications

9001:2015

27001:2022

MACULAR DEGENERATION TREATMENT MARKET ANALYSIS

Leading Companies

Macular Degeneration Treatment Market Report Snapshots

EXISTING CLIENTELE